Nutex Health, Inc. (NUTX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 72 transactions totaling $3.8M, demonstrating a bearish sentiment with -$1.2M in net insider flow. The most recent transaction on Nov 25, 2025 involved a purchase of 750 shares valued at $102.5K.
No significant insider buying has been recorded for NUTX in the recent period.
No significant insider selling has been recorded for NUTX in the recent period.
Based on recent SEC filings, insider sentiment for NUTX is bearish with an Insider Alignment Score of 34/100 and a net flow of -$1.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Nutex Health, Inc. (NUTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading NUTX stock, having executed 72 transactions in the past 90 days. The most active insider is Warren Hosseinion (Executive), who has made 9 transactions totaling $2.1M.
Get notified when executives and directors at NUTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Christian Bates Jon | Executive | Purchase | 750 | $136.71 | $102.5K | |
| Jul 14, 2025 | E. Jaumot Frank | Executive | Award | 603 | $N/A | $0 | |
| Jul 14, 2025 | Yvonne Grenas Cheryl | Executive | Award | 603 | $N/A | $0 | |
| Jul 14, 2025 | Lee Reed Michael | Executive | Award | 603 | $N/A | $0 | |
| Jul 14, 2025 | J. Saunders Scott | Executive | Award | 603 | $N/A | $0 | |
| Sep 6, 2024 | Dogan Timur | Executive | Purchase | 68,965 | $0.29 | $20.0K | |
| Aug 22, 2024 | Christian Bates Jon | Executive | Purchase | 1,350 | $21.46 | $29.0K | |
| Aug 20, 2024 | Detillio Joshua | Executive | Purchase | 575 | $17.40 | $10.0K | |
| Aug 19, 2024 | Detillio Joshua | Executive | Purchase | 1,300 | $17.85 | $23.2K | |
| Jul 12, 2024 | T. Vo Thomas | Executive | Award | 22,709 | $N/A | $0 | |
| Jun 12, 2024 | Detillio Joshua | Executive | Purchase | 20,000 | $0.54 | $10.8K | |
| May 30, 2024 | T. Vo Thomas | Executive | Purchase | 2,986 | $0.66 | $2.0K | |
| May 29, 2024 | T. Vo Thomas | Executive | Purchase | 3,768 | $0.68 | $2.6K | |
| May 28, 2024 | T. Vo Thomas | Executive | Purchase | 48,394 | $0.70 | $33.9K | |
| May 13, 2024 | T. Vo Thomas | Executive | Purchase | 17,330 | $0.69 | $12.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 11 | $2.5M | 54.7% |
Purchase(P) | 27 | $1.3M | 28.0% |
Award(A) | 18 | $650.0K | 14.2% |
Conversion(C) | 2 | $130.4K | 2.8% |
Exercise (Options)(X) | 1 | $15.2K | 0.3% |
Exercise(M) | 5 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at Nutex Health, Inc. has increased, with 17 insiders executing 72 transactions across all time. Total sales of $2.5M significantly outpace purchases of $1.3M, resulting in a net outflow of $1.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.